05:45 PM EDT, 05/22/2025 (MT Newswires) -- ABVC BioPharma ( ABVC ) filed a registration statement late Thursday for the potential sale of up to $100 million of its securities from time to time in one or more offerings.
The filing covers common and preferred stock, warrants, units, debt securities, and subscription rights, according to the filing.
The company said it will use the net proceeds for general corporate purposes.